Over her 30+ years at Skadden, Eileen Nugent has emerged as one of the most respected and influential M&A attorneys in the world, advising on cutting edge matters across the deal landscape. Public company boards of directors and private equity funds have routinely called on Eileen for her wisdom, creativity and, above all, incomparable deal sense and judgment.

Her ability to innovate has repeatedly set her apart and literally changed how practitioners think about deals, from high-profile contested situations, like Warner Lambert’s acquisition by Pfizer and Cephalon’s defense against an unsolicited bid by Valeant and sale to Teva, to groundbreaking approaches to LBOs, such as Burger King’s acquisition by 3G and Avaya’s acquisition by Silver Lake and TPG. Beyond transactional brilliance, Eileen’s presence has been felt deeply as a long-term constant in boardrooms, including her decades-long work for Endo and guidance of American Standard through a whole-company transformation.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]